Funding
← Back to your selection

Lifespan Vision Ventures

Activity from announced rounds

All recorded activity
Rounds participated in
3
Confirmed lead rounds
—
3 roles undisclosed
New companies
3
First participation on record · 0 follow-on
Funding in participating rounds
$18.5M
3 disclosed · full round size, not this investor’s share

By stage

Pre-seed1
Seed1
Series A1

By primary sector

Biotech3

By country

United States3

Rounds

3 in all activity
Remedium Bio

Develops durable protein therapeutics via gene therapy for chronic diseases

$10MSeries A
Role not disclosed
Violet Therapeutics

Develops first-in-class small molecule therapies for neurodegenerative disease via glial cell signaling platform

$4.8MSeed+
Role not disclosed
Sift Biosciences

Develops next-generation peptide immunotherapy platform using AI metagenomics and high-throughput profiling to engage memory T cells for cancer and autoimmune diseases

$3.7MPre-Seed
Role not disclosed